Avalo Therapeutics (AVTX) Net Margin Growth (3y) (2019 - 2024)
Avalo Therapeutics (AVTX) Net Margin Growth (3y) (2019 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 9,283.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 506.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -569.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 6,537.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Avalo Therapeutics | 1.04 Mn | 1.04 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -1.84 Mn |
| Sep 30, 2024 | 924,618.00 |
| Dec 31, 2023 | -146,381.00 |
| Sep 30, 2023 | -219,743.00 |
| Jun 30, 2023 | -124,018.00 |
| Mar 31, 2023 | -213,348.00 |
| Dec 31, 2021 | -4,204.00 |
| Sep 30, 2021 | 60,940.00 |
| Jun 30, 2021 | 12,760.00 |
| Mar 31, 2021 | 6,421.00 |
| Dec 31, 2020 | 19,511.00 |
| Sep 30, 2020 | -9,259.00 |
| Jun 30, 2020 | 110,574.00 |
| Mar 31, 2020 | 54,800.00 |
| Dec 31, 2019 | 108,366.00 |
| Sep 30, 2019 | 186,942.00 |
| Jun 30, 2019 | 29,435.00 |